Abbott eyes intravascular lithotripsy market with clinical trial approval
The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company's coronary intravascular lithotripsy (IVL) system in a clinical trial.
The TECTONIC trial will evaluate the yet unnamed system for the treatment of severe calcification in coronary arteries before implanting a stent. A total of 335 people are expected to be enrolled across 47 sites in the US.
IVL uses sound waves to break up calcified portions of vessels. The high-frequency, pulsatile pressure fragments calcium lesions and helps restore vessel patency.
Though brief on details, Abbott system follows a similar technical vein to other IVL devices. The company says its investigational system uses high-energy sound pressure waves to treat calcium blockages and potentially allow for better stent placement.
Abbott's trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access to the Shockwave systems through a $13.1bn acquisition of Shockwave Medical in 2024 – still the largest ever medtech deal to date.
Both J&J and Boston Scientific have since doubled down their presence in the market, the newest part of the atherectomy device sector is forecast to grow to over $2bn in value by 2034, as per analysis by GlobalData. Boston spent $664m to acquire IVL specialist Bolt Medical in January this year, whilst J&J expanded its product range with the launch of the Shockwave Javelin Peripheral IVL Catheter.
There are multiple early-stage companies developing technology in the field too, including Amplitude Vascular Systems and Elixir Medical, both of whom have reported positive clinical data.
IVL is being used for coronary and peripheral artery disease, with the former being the more common type of heart disease, affecting 1 in 20 adults in the US.
Abbott's divisional vice president of global clinical affairs at Abbott's vascular business, Jennifer Jones-McMeans, said the clinical trial with its new system is exploring the next generation of calcium modification technology and advancing the company's portfolio of coronary artery disease treatments.
The IVL trial initiation comes months after Abbott's orbital atherectomy system failed a trial in October 2024. The Diamondback 360 system, acquired in a $890m buyout of cardiovascular specialist CSI, showed no difference in treating calcified lesions compared to balloon angioplasty.
Abbott generated $42bn in revenue for 2024, a 4.3% rise from 2023, driven primarily by diabetes device sales. The company has issued organic sales growth guidance between 7.5% and 8.5%.
"Abbott eyes intravascular lithotripsy market with clinical trial approval" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak
A Maryland food company has recalled specific salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. TGD Cuts, LLC of Jessup, Maryland, is recalling some tub and tray products because they contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc., which have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration (FDA). The products had use-by dates ranging from May 20 to May 28 and are unlikely to be in stores or being used. No illnesses have been reported in connection with the products, the FDA said. Egg recall: Brown eggs sold at some Walmart stores have salmonella risk The initial May 19 recall involved cucumbers sold directly to consumers at Bednar's Farm Fresh Market, according to notices published May 19 by the Centers for Disease Control and Prevention (CDC) and the FDA. Subsequent recalls have been announced by grocers such as Harris Teeter, Kroger and Walmart for repackaged cucumbers for resale under different brand names or those used in ready-to-eat products, including vegetable trays and salads. The cucumbers, distributed by Fresh Start Produce Sales of Delray, Florida, also led to Target recalling individual cucumbers on May 30, specifically cucumber two-packs and various prepared foods products. In addition to the growing cucumber-related recall, other products have been recalled recently for potential salmonella contamination. The FDA on May 28 upgraded a recall of tomatoes distributed in three southern states to a Class I recall, meaning consumption of the food could cause serious health complications or lead to death. Then, on June 6, the CDC and FDA linked brown eggs sold in nine states – including at some Walmart stores – to an ongoing Salmonella Enteritidis outbreak, in which 79 people have been sickened and at least 21 hospitalized. Customers who purchased any products from TGD Cuts should get rid of them or return them for a full refund. Here is the list of products recalled due to a possible salmonella risk. Item UPC Use By Date Salsa, Hot 6/12 oz. 840219170534 5/25/2025 Salsa, Mild 6/12 oz. 840219170541 5/25/2025 Salsa, Mild 5lb. 840219140445 not available Salsa, Mild 5lb. 840219140445 5/28/2025 Cucumber Sliced/Grape Tomato 50/2 oz. 840219184784 5/23/2025 Cucumber Sliced Unpeeled 5lb. 840219160733 not available Cucumber Sliced Unpeeled 50/2 oz. 840219170657 5/19/2025 Cucumber Spears 50/2 oz. 840219179971 5/19/2025 Salmonella poisoning causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms, which include diarrhea, fever and stomach cramps, will usually occur six hours to six days after exposure and may last up to seven days. Symptoms from severe infections may include aches, headaches, elevated fever, lethargy, rashes, and blood in urine or stool. Mike Snider is a reporter on USA TODAY's Trending team. You can follow him on Threads, Bluesky, X and email him at mikegsnider & @ & @mikesnider & msnider@ What's everyone talking about? Sign up for our trending newsletter to get the latest news of the day This article originally appeared on USA TODAY: More cucumbers recalled for salmonella risk, FDA says
Yahoo
an hour ago
- Yahoo
Ro Weight Loss Announces Official Website Update Featuring Natural Daily Program for Medically-Guided Weight Management
Digital health platform offers FDA-approved treatments when appropriate and personalized care plans through licensed providers. New York, June 07, 2025 (GLOBE NEWSWIRE) -- Ro Weight Loss, a digital health service from Roman Health Ventures Inc., has updated its official website to provide new information about its medically-guided weight management program. Designed for adults across the United States, the offering connects eligible individuals with licensed healthcare providers through a secure telehealth platform. According to the official website ( Ro Weight Loss offers a structured approach to weight care, including FDA-approved treatment options when appropriate, along with personalized clinical support and lifestyle guidance. The service is designed to be accessible from home and does not require in-person clinic visits or restrictive dietary regimens. 'We created Ro Weight Loss to make effective, evidence-backed care more accessible,' said a Ro spokesperson. 'Our platform empowers people with a personalized plan, clinical oversight, and flexible support tailored to their health goals.' Ro states that the program prioritizes safety, transparency, and sustainable progress. After completing an online health assessment, users may be evaluated by board-certified providers to determine medical eligibility. When appropriate, providers may prescribe treatment as part of a comprehensive plan that includes coaching and follow-up. All care is delivered by licensed professionals, and medications are dispensed by U.S.-based pharmacies. The platform supports discreet access to care, ongoing communication with providers, and convenience for users managing their health goals remotely. The Ro Weight Loss program is currently available in all 50 states. Individuals interested in exploring eligibility or learning more about the service can visit the official website for additional information. About Ro Weight Loss Ro Weight Loss is a service provided by Roman Health Ventures Inc., a New York-based telehealth company offering evidence-based treatment across multiple areas of care, including weight management, mental health, dermatology, and more. Ro's digital platform empowers individuals to receive safe, personalized healthcare from the comfort of home. Product and Contact Information Brand: Ro Weight LossWebsite: care@ Address:Roman Health Ventures Inc.625 6th Ave, 4th FloorNew York, NY 10011 Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this program have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new treatment plan. Affiliate Disclosure This news release contains affiliate links. If you purchase through these links, the publisher may earn a commission at no additional cost to you. This disclosure complies with the Federal Trade Commission's guidelines on endorsements and testimonials in advertising. All opinions expressed are strictly those of the author or publisher. CONTACT: Email: care@
USA Today
an hour ago
- USA Today
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak Show Caption Hide Caption 'Deadly' tomatoes in southern states recalled by FDA due to salmonella Tomatoes distributed in Georgia, North Carolina, and South Carolina are under a Class I recall due to potential salmonella contamination, according to the FDA. unbranded - Newsworthy A Maryland food company has recalled specific salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. TGD Cuts, LLC of Jessup, Maryland, is recalling some tub and tray products because they contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc., which have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration (FDA). The products had use-by dates ranging from May 20 to May 28 and are unlikely to be in stores or being used. No illnesses have been reported in connection with the products, the FDA said. Egg recall: Brown eggs sold at some Walmart stores have salmonella risk Recall of cucumbers for salmonella risk expands The initial May 19 recall involved cucumbers sold directly to consumers at Bednar's Farm Fresh Market, according to notices published May 19 by the Centers for Disease Control and Prevention (CDC) and the FDA. Subsequent recalls have been announced by grocers such as Harris Teeter, Kroger and Walmart for repackaged cucumbers for resale under different brand names or those used in ready-to-eat products, including vegetable trays and salads. The cucumbers, distributed by Fresh Start Produce Sales of Delray, Florida, also led to Target recalling individual cucumbers on May 30, specifically cucumber two-packs and various prepared foods products. Salmonella risks prompt egg, tomato recalls In addition to the growing cucumber-related recall, other products have been recalled recently for potential salmonella contamination. The FDA on May 28 upgraded a recall of tomatoes distributed in three southern states to a Class I recall, meaning consumption of the food could cause serious health complications or lead to death. Then, on June 6, the CDC and FDA linked brown eggs sold in nine states – including at some Walmart stores – to an ongoing Salmonella Enteritidis outbreak, in which 79 people have been sickened and at least 21 hospitalized. The latest: What cucumbers and products have been recalled Customers who purchased any products from TGD Cuts should get rid of them or return them for a full refund. Here is the list of products recalled due to a possible salmonella risk. Item UPC Use By Date Salsa, Hot 6/12 oz. 840219170534 5/25/2025 Salsa, Mild 6/12 oz. 840219170541 5/25/2025 Salsa, Mild 5lb. 840219140445 not available Salsa, Mild 5lb. 840219140445 5/28/2025 Cucumber Sliced/Grape Tomato 50/2 oz. 840219184784 5/23/2025 Cucumber Sliced Unpeeled 5lb. 840219160733 not available Cucumber Sliced Unpeeled 50/2 oz. 840219170657 5/19/2025 Cucumber Spears 50/2 oz. 840219179971 5/19/2025 What are salmonella poisoning symptoms? Salmonella poisoning causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms, which include diarrhea, fever and stomach cramps, will usually occur six hours to six days after exposure and may last up to seven days. Symptoms from severe infections may include aches, headaches, elevated fever, lethargy, rashes, and blood in urine or stool. Mike Snider is a reporter on USA TODAY's Trending team. You can follow him on Threads, Bluesky, X and email him at mikegsnider & @ & @mikesnider & msnider@ What's everyone talking about? Sign up for our trending newsletter to get the latest news of the day
